Murine hematopoietic stem cell transduction using retroviral vectors

Area of Science:

• * Hematology
• * Molecular Biology
• * Gene Therapy

Background:

• * Hematopoietic stem cells (HSCs) are crucial for bone marrow transplantation and gene therapy.
• * Gene therapy aims to correct inherited diseases by modifying HSCs, impacting all blood lineages.
• * Mouse models are essential for validating human gene therapy strategies.

Purpose of the Study:

• * To provide a detailed protocol for retroviral transduction of murine lineage-negative cells.
• * To establish a reproducible method for gene therapy research using mouse models.
• * To facilitate the development of HSC-based gene therapies for inherited blood disorders.

Main Methods:

• * Isolation of stem-cell-enriched lineage-negative cells from murine bone marrow.
• * Efficient transduction of these cells using retroviral vectors (gammaretroviral and lentiviral).
• * Step-by-step protocol for the transduction process.

Main Results:

• * Successful transduction of murine lineage-negative cells was achieved.
• * The protocol enables efficient gene delivery to HSC functional equivalents.
• * Validated the use of mouse models for gene therapy concept testing.

Conclusions:

• * Retroviral transduction of murine lineage-negative cells is a feasible and effective method.
• * This protocol supports the development and validation of HSC gene therapies.
• * Essential for advancing gene therapy applications for inherited diseases.